Body Mass Index as a Predictive Factor of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Patients

被引：0
|
作者：
Bellet Ezquerra, M. [1 ]
Perez Garcia, J. M. [1 ]
Munoz Couselo, E. [1 ]
SauraManich, C. [1 ]
Gomez Pardo, P. [1 ]
Vidal, M. [1 ]
Argiles, G. [1 ]
De Mattos, L. [1 ]
Cortes Castan, J. [1 ]
Baselga Torres, J. [1 ]
机构：
[1] Vall dHebron Univ Hosp, Vall dHebron Inst Oncol, Barcelona, Catalunya, Spain
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-P4-03-04
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P4-03-04
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Pathological complete response following neoadjuvant chemotherapy in operable breast cancer patients: Is obesity a predictive factor?
    Wang, Haiyun
    Zhang, Shijia
    Yee, Douglas
    Beckwith, Heather
    Potter, David
    Blaes, Anne
    [J]. CANCER RESEARCH, 2020, 80 (04)
  • [2] The Predictive Importance of Body-Mass Index on Response to Neoadjuvant Chemotherapy in Patients with Breast Cancer
    Emirzeoglu, Levent
    Arici, Serdar
    Sahin, Ahmet Bilgehan
    Ocak, Birol
    Ak, Naziye
    Ay, Seval
    Mammadov, Elkhan
    Turna, Hande
    Bilici, Ahmet
    [J]. BREAST CARE, 2023, 18 (01) : 42 - 48
  • [3] Body mass index and response to neoadjuvant chemotherapy in breast cancer patients
    Litton, J. K.
    Gonzalez, A. M.
    Warneke, C. L.
    Kau, S.
    Buzdar, A. U.
    Bondy, M.
    Mahabir, S.
    Hortobagyi, G. N.
    Brewster, A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [4] Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
    Jie Dong
    Qingqing Sun
    Yueyin Pan
    Nannan Lu
    Xinghua Han
    Qiong Zhou
    [J]. BMC Cancer, 21
  • [5] Pretreatment systemic inflammation response index is predictive of pathological complete response in patients with breast cancer receiving neoadjuvant chemotherapy
    Dong, Jie
    Sun, Qingqing
    Pan, Yueyin
    Lu, Nannan
    Han, Xinghua
    Zhou, Qiong
    [J]. BMC CANCER, 2021, 21 (01)
  • [6] The association between body mass index and pathological complete response in neoadjuvant-treated breast cancer patients
    Skarping, Ida
    Blaabjerg Pedersen, Stine
    Fornvik, Daniel
    Zackrisson, Sophia
    Borgquist, Signe
    [J]. ACTA ONCOLOGICA, 2022, 61 (06) : 731 - 737
  • [7] Predictive factors of pathological complete response by neoadjuvant chemotherapy for operable breast cancer
    Ishikawa, Takashi
    Shimizu, Daisuke
    Sasaki, Takashi
    Morita, Satoshi
    Tanabe, Mikiko
    Ota, Ikuko
    Kawachi, Kae
    Chishima, Takashi
    Ichikawa, Yasushi
    Endo, Itaru
    [J]. CANCER RESEARCH, 2011, 71
  • [8] Impact of body mass index (BMI) on pathological complete response (pCR) and survival of breast cancer (BC) patients receiving neoadjuvant chemotherapy (NAC)
    Aguiar Bujanda, D.
    Ros Sanjuan, L.
    Perez Cabrera, D.
    Croissier Sanchez, L.
    Mori De Santiago, M.
    Hernandez Sosa, M.
    Vargas Prado, A. M.
    Galvan Ruiz, S.
    Antonilli Perez, C.
    Ten Benajes, R.
    Fox, B.
    Martinez Garcia-Cervantes, R.
    Rubio Romero, G.
    Hanselmann, R.
    Saura Grau, S.
    [J]. ANNALS OF ONCOLOGY, 2021, 32 : S51 - S52
  • [9] Association of body mass index with pathological complete response after neoadjuvant chemotherapy in a population-based cohort of Black breast cancer patients
    Omene, Coral
    Amin, Saber
    Zeinomar, Nur
    Qin, Bo
    Chanumolu, Dhanya
    Llanos, Adana A. M.
    Hong, Chi-Chen
    Demissie, Kitaw
    Bandera, Elisa V.
    [J]. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [10] Impact of body mass index on pathological complete response following neoadjuvant chemotherapy in operable breast cancer: a meta-analysis
    Haiyun Wang
    Shijia Zhang
    Douglas Yee
    Saonli Basu
    Heather Beckwith
    David Potter
    Anne Blaes
    [J]. Breast Cancer, 2021, 28 : 618 - 629
12345